Organic compounds -- part of the class 532-570 series – Organic compounds – Sulfonic acids or salts thereof
Reexamination Certificate
2011-06-07
2011-06-07
Puttlitz, Karl J (Department: 1621)
Organic compounds -- part of the class 532-570 series
Organic compounds
Sulfonic acids or salts thereof
Reexamination Certificate
active
07956214
ABSTRACT:
Provided are processes for the synthesis of aniline derivatives, specifically certain aniline derivatives which have activity as thyroid receptor ligands.
REFERENCES:
patent: 2596393 (1952-05-01), Fitz Gerald
patent: 3544623 (1970-12-01), Hansen et al.
patent: 3674836 (1972-07-01), Creger
patent: 3879557 (1975-04-01), Kaiser et al.
patent: 3983140 (1976-09-01), Endo et al.
patent: 4027009 (1977-05-01), Grier et al.
patent: 4231938 (1980-11-01), Monaghan et al.
patent: 4346227 (1982-08-01), Terahara et al.
patent: 4379785 (1983-04-01), Weyer et al.
patent: 4448784 (1984-05-01), Glamkowski et al.
patent: 4450171 (1984-05-01), Hoffman et al.
patent: 4499289 (1985-02-01), Baran et al.
patent: 4572912 (1986-02-01), Yoshioka et al.
patent: 4613610 (1986-09-01), Wareing
patent: 4639436 (1987-01-01), Junge et al.
patent: 4647576 (1987-03-01), Hoefle et al.
patent: 4681893 (1987-07-01), Roth
patent: 4686237 (1987-08-01), Anderson
patent: 4759923 (1988-07-01), Buntin et al.
patent: 4871721 (1989-10-01), Biller
patent: 4904769 (1990-02-01), Rauenbusch
patent: 4924024 (1990-05-01), Biller
patent: 5006530 (1991-04-01), Angerbauer et al.
patent: 5177080 (1993-01-01), Angerbauer et al.
patent: 5273995 (1993-12-01), Roth
patent: 5346701 (1994-09-01), Heiber et al.
patent: 5354772 (1994-10-01), Kathawala
patent: 5385929 (1995-01-01), Bjorge et al.
patent: 5401772 (1995-03-01), Yokoyama et al.
patent: 5569674 (1996-10-01), Yokoyama et al.
patent: 5594016 (1997-01-01), Ueno et al.
patent: 5595872 (1997-01-01), Wetterau, II et al.
patent: 5614492 (1997-03-01), Habener
patent: 5631224 (1997-05-01), Efendic et al.
patent: 5654468 (1997-08-01), Yokoyama et al.
patent: 5686104 (1997-11-01), Mills et al.
patent: 5712279 (1998-01-01), Biller et al.
patent: 5712396 (1998-01-01), Magnin et al.
patent: 5739135 (1998-04-01), Biller et al.
patent: 5760246 (1998-06-01), Biller et al.
patent: 5827875 (1998-10-01), Dickson, Jr. et al.
patent: 5885983 (1999-03-01), Biller et al.
patent: 5962440 (1999-10-01), Sulsky
patent: 6194454 (2001-02-01), Dow
patent: 6414126 (2002-07-01), Ellsworth et al.
patent: 6548529 (2003-04-01), Robl et al.
patent: 2001/0051657 (2001-12-01), Chiang et al.
patent: 0 142 146 (1985-05-01), None
patent: 0 221 025 (1987-05-01), None
patent: 2 205 837 (1988-12-01), None
patent: 03-291241 (1991-12-01), None
patent: WO 86/03488 (1986-06-01), None
patent: WO 86/07054 (1986-12-01), None
patent: WO 01/60784 (2001-08-01), None
patent: WO 01/72692 (2001-10-01), None
Gilman et al., Journal of the American Chemical Society (1935), 57, 909-12.
Biller, S.A. et al., “Isoprenoid (Phosphinylmethyl)phosphonates as Inhibitors of Squalene Synthetase”, Journal of Medicinal Chemistry, vol. 31, No. 10, pp. 1869-1871 (1988).
Biller, S.A. et al., “Squalene Synthase Inhibitors”, Current Pharmaceutical Design, vol. 2, pp. 1-40 (1996).
Blank, B. et al., “Thyromimetics. I. The Synthesis and Hypocholesteremic Activity of Some 3′ and 3′,5′-Alkyl and Aryl-3,5-diiodothyronines”, J. Med. Chem., vol. 6, pp. 554-560 (1963).
Bowman, D.F. et al., “Oxidation of Alkoxyphenols. Part VIII. Further Examples of Trimerisation to Spiroketals”, J. Chem. Soc. (C), pp. 2274-2279 (1966).
Bozell, J.J. et al., “Catalytic Oxidation of Para-Substituted Phenols with Nitrogen Dioxide and Oxygen”, Tetrahedron Letters, vol. 39, pp. 2261-2264 (1998).
Capson, T.L., “Synthesis and Evaluation of Ammonium Analogs of Carbocationic Intermediates in Squalene Biosynthesis”, dissertation, Department of Medicinal Chemistry, University of Utah, pp. iv-v, Table of Contents, 16-17, 40-43, 48-51, Summary (Jun. 1987).
Carey, F.A. et al, Section 5.6: “Leaving Group Effects”, Advanced Organic Chemistry, Third Edition, Part A: Structure and Mechanisms, Plenum Press, publ., pp. 290-293 (1977).
Clewley, R.G. et al., “Formation of 4-Halo-4-nitrocyclohexa-2,5-dienones on Nitration ofp-Halophenols andp-Halophenyl Acetates”, Tetrahedron, vol. 45, No. 5, pp. 1299-1310 (1989).
Clewley, R.G. et al., “ipsoNitration inp-halophenyl ethers”, Can J. Chem., vol. 67, pp. 1472-1479 (1989).
Corey, E.J. et al., “Application of Unreactive Analogs of Terpenoid Pyrophosphates to Studies of Multistep Biosynthesis. Demonstration That ‘Presqualene Pyrophosphate’ Is an Essential Intermediate on the Path to Squalene”, J. Am. Chem. Soc., vol. 98, No. 5, pp. 1291-1293 (1976).
Fischer, A. et al., “Formation of Dienones on the Reaction of Cresols, Xylenols, and 2-naphthol with Nitrogen Dioxide: Observation of Keto Tautomers of Nitrophenols”, Tetrahedron Letters, vol. 29, No. 16, pp. 1869-1872 (1988).
Gaude, D. et al., “Influence de la complexation sur la réactivité de nitrates d'halogènes”, Can. J. Chem., vol. 67, pp. 104-108 (1989).
Ghiselli, G., “The Pharmacological Profile of FCE 27677: A Novel ACAT Inhibitor with Potent Hypolipidemic Activity Mediated by Selective Suppression of the Hepatic Secretion of ApoB-100-Containing Lipoprotein”, Cardiovascular Drug Reviews, vol. 16, No. 1, pp. 16-30 (1998).
Greene, T.W. et al., Protective Groups in Organic Synthesis, Third Edition, John Wiley & Sons, Inc., publ., pp. xi-xii (table of contents) (1999).
Hara, S., “Ileal Na+/bile acid cotransporter inhibitors”, Drugs of the Future, vol. 24, No. 4, pp. 425-430 (1999).
Kajigaeshi, S. et al., “Bromination of Phenols by Use of Benzyltrimethylammonium Chlorobromate (1-)”, Technol. Rep. Yamaguchi Univ., vol. 4, pp. 65-69 (1987).
Kajigaeshi, S. et al., “Bromination of Phenols by Use of Benzyltrimethylammonium Tribromide”, Chemistry Letters, pp. 627-630 (1987).
Kajigaeshi, S. et al., “Chlorination of Phenols with Benzyltrimethylammonium Tetrachloroiodate”, Chemistry Express, vol. 5, No. 3, pp. 141-144 (1990).
Kajigaeshi, S. et al., “Halogenation Using Quaternary Ammonium Polyhalides. IV. Selective Bromination of Phenols by Use of Tetraalkylammonium Tribromides”, Bull. Chem. Soc. Jpn., vol. 60, pp. 4187-4189 (1987).
Kajigaeshi, S. et al., “Iodination of Phenols by Use of Benzyltrimethylammonium Dichlordodate(1-)”, Chemistry Letters, pp. 2109-2112 (1987).
Kakinami, T. et al., “Halogenation Using Quarternary Ammonium Polyhalides. XX. Bromination of Phenols with Polymer-Bound Benzyltrimethylammonium Tribromide”, Bull. Chem. Soc. Jpn., vol. 62, pp. 3373-3375 (1989).
Krause, B.R. et al., Chapter 6: “ACAT Inhibitors: Physiologic Mechanisms for Hypolipidemic and Anti-Atherosclerotic Activities in Experimental Animals”, Inflammation: Mediators and Pathways, CRC Press Inc., publ., Ruffolo, Jr., R.R. and Hollinger, M.A., eds., pp. 173-198 (1995).
Lemaire, M. et al., “Nitrocyclohexadienones: A New Class of Nitrating Agents”, Tetrahedron, vol. 43, No. 5, pp. 835-844 (1987).
McClard, R.W. et al., “Novel Phosphonylphosphinyl (P-C-P-C-) Analogues of Biochemically Interesting Diphosphates. Syntheses and Properties of P-C-P-C- Analogues of Isopentenyl Diphosphate and Dimethylallyl Diphosphate”, J. Am. Chem. Soc., vol. 109, pp. 5544-5545 (1987).
Murakami, K. et al., “A Novel Insulin Sensitizer Acts as a Coligand for Peroxisome Proliferator-Activated Receptor-α (PPARα) and PPAR-γ, etc.”, Diabetes, vol. 47, pp. 1841-1847 (1998).
Nicolosi, R.J. et al., “The ACAT Inhibitor, CI-1011 is effective in the prevention and regression of aortic fatty streak area in hamsters”, Atherosclerosis, vol. 137, pp. 77-85 (1998).
Ortiz de Montellano, P.R. et al., “Inhibition of Squalene Synthetase by Farnesyl Pyrophosphate Analogues”, Journal of Medicinal Chemistry, vol. 20, No. 2, pp. 243-249 (1977).
Rodygin, M.Y. et al., “Bis[diemthylacetamide]hydrogen Dibromobromate—A New Brominating Agent”, Zh. Org. Khim., pp. 1543-1544 (1992) (English translation).
Rosenblum, S.B. et al., “Discovery of
Chidambaram Ramakrishnan
Ghosh Arun
Kant Joydeep
Weaver Raymond E.
Yu Jurong
Bristol--Myers Squibb Company
Garabedian Todd E.
Karo Bio AB
Puttlitz Karl J
Wiggin and Dana LLP
LandOfFree
Process for the preparation of aniline-derived thyroid... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Process for the preparation of aniline-derived thyroid..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Process for the preparation of aniline-derived thyroid... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2675639